HUT67301A - Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising them - Google Patents
Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising themInfo
- Publication number
- HUT67301A HUT67301A HU9302433A HU9302433A HUT67301A HU T67301 A HUT67301 A HU T67301A HU 9302433 A HU9302433 A HU 9302433A HU 9302433 A HU9302433 A HU 9302433A HU T67301 A HUT67301 A HU T67301A
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- nmda antagonists
- derivatives
- quinolinic
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66178091A | 1991-02-27 | 1991-02-27 | |
| US70000491A | 1991-05-14 | 1991-05-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9302433D0 HU9302433D0 (en) | 1993-11-29 |
| HUT67301A true HUT67301A (en) | 1995-03-28 |
| HU217425B HU217425B (hu) | 2000-01-28 |
Family
ID=27098383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9302433A HU217425B (hu) | 1991-02-27 | 1992-02-11 | Eljárás NMDA antagonista hatású kinolinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0573562B1 (hu) |
| JP (1) | JP3465794B2 (hu) |
| KR (1) | KR100224045B1 (hu) |
| AT (1) | ATE137225T1 (hu) |
| AU (1) | AU660969B2 (hu) |
| CA (1) | CA2104297C (hu) |
| DE (1) | DE69210229T2 (hu) |
| DK (1) | DK0573562T3 (hu) |
| ES (1) | ES2089511T3 (hu) |
| FI (1) | FI103202B1 (hu) |
| GR (1) | GR3019772T3 (hu) |
| HU (1) | HU217425B (hu) |
| NO (1) | NO180485C (hu) |
| WO (1) | WO1992015565A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
| PT647137E (pt) * | 1992-06-22 | 2008-11-24 | Univ California | Antagonistas dos receptores da glicina e a sua utilização |
| US5475007A (en) * | 1993-05-28 | 1995-12-12 | The Regents Of The University Of California | 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof |
| ES2129794T3 (es) * | 1993-11-29 | 1999-06-16 | Merrell Pharma Inc | Derivados de bencenosulfonilimina heterociclicos como inhibidores de la accion de il-1. |
| PT731791E (pt) * | 1993-11-29 | 2000-11-30 | Merrell Pharma Inc | Novos derivados de benzeno-sulfonil-imina como inibidores da accao da il-1. |
| CA2788656A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719102D0 (en) * | 1987-08-12 | 1987-09-16 | Merck Sharp & Dohme | Therapeutic agents |
| EP0386839B1 (en) * | 1989-03-08 | 1997-01-15 | Merck Sharp & Dohme Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
| AU626418B2 (en) * | 1989-05-16 | 1992-07-30 | Merrell Pharmaceuticals Inc. | Excitatory amino acid antagonists |
-
1992
- 1992-02-11 ES ES92907466T patent/ES2089511T3/es not_active Expired - Lifetime
- 1992-02-11 WO PCT/US1992/001093 patent/WO1992015565A1/en not_active Ceased
- 1992-02-11 KR KR1019930702559A patent/KR100224045B1/ko not_active Expired - Fee Related
- 1992-02-11 AU AU15320/92A patent/AU660969B2/en not_active Ceased
- 1992-02-11 CA CA002104297A patent/CA2104297C/en not_active Expired - Lifetime
- 1992-02-11 DE DE69210229T patent/DE69210229T2/de not_active Expired - Lifetime
- 1992-02-11 JP JP50728592A patent/JP3465794B2/ja not_active Expired - Lifetime
- 1992-02-11 EP EP92907466A patent/EP0573562B1/en not_active Expired - Lifetime
- 1992-02-11 HU HU9302433A patent/HU217425B/hu not_active IP Right Cessation
- 1992-02-11 DK DK92907466.4T patent/DK0573562T3/da active
- 1992-02-11 AT AT92907466T patent/ATE137225T1/de not_active IP Right Cessation
-
1993
- 1993-08-26 NO NO933042A patent/NO180485C/no not_active IP Right Cessation
- 1993-08-26 FI FI933762A patent/FI103202B1/fi active
-
1996
- 1996-04-25 GR GR960401099T patent/GR3019772T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2089511T3 (es) | 1996-10-01 |
| AU1532092A (en) | 1992-10-06 |
| EP0573562B1 (en) | 1996-04-24 |
| DK0573562T3 (da) | 1996-05-13 |
| WO1992015565A1 (en) | 1992-09-17 |
| NO180485C (no) | 1997-04-30 |
| CA2104297A1 (en) | 1992-08-28 |
| EP0573562A1 (en) | 1993-12-15 |
| DE69210229T2 (de) | 1996-11-14 |
| JPH06505746A (ja) | 1994-06-30 |
| CA2104297C (en) | 2003-05-27 |
| HU217425B (hu) | 2000-01-28 |
| KR930703257A (ko) | 1993-11-29 |
| FI933762A0 (fi) | 1993-08-26 |
| HU9302433D0 (en) | 1993-11-29 |
| JP3465794B2 (ja) | 2003-11-10 |
| DE69210229D1 (de) | 1996-05-30 |
| GR3019772T3 (en) | 1996-07-31 |
| ATE137225T1 (de) | 1996-05-15 |
| KR100224045B1 (ko) | 1999-10-15 |
| NO933042L (no) | 1993-08-26 |
| FI103202B (fi) | 1999-05-14 |
| FI933762L (fi) | 1993-08-26 |
| FI103202B1 (fi) | 1999-05-14 |
| AU660969B2 (en) | 1995-07-13 |
| NO933042D0 (no) | 1993-08-26 |
| NO180485B (no) | 1997-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| FI934274A7 (fi) | N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset | |
| FI935073A7 (fi) | Uusia tiopyranopyrrolijohdannaisia, niiden valmistus ja niitä sisältäv ät farmaseuttiset koostumukset | |
| NZ237041A (en) | Substituted 1h-indole derivatives, preparation, pharmaceutical compositions and intermediates thereof | |
| ZA915759B (en) | Substituted bicyclic bis-aryl compounds,their preparation and pharmaceutical compositions containing them | |
| UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
| FI942913L (fi) | Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| AU8676091A (en) | 3-amidoindolyl derivatives | |
| HUT67237A (en) | Excitatory amino acid antagonists indole derivatives, their preparation and pharmaceutical compositions comprising them | |
| FI951789A7 (fi) | Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farma seuttiset koostumukset | |
| NO302368B1 (no) | Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene | |
| FI943645A7 (fi) | Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niid en valmistus ja niitä sisältäviä farmaseuttisia koostumuksia | |
| ES2062137T3 (es) | Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea. | |
| CA2061836A1 (en) | Nmda antagonists | |
| HUT67301A (en) | Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising them | |
| IL103524A0 (en) | Benzenesulfonamide derivatives,their preparation and pharmaceutical compositions containing them | |
| ES2105605T3 (es) | Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas. | |
| NZ241287A (en) | Sulphonamide derivatives, preparation and pharmaceutical compositions thereof | |
| FI941517A7 (fi) | Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| FI922773A7 (fi) | Uudet p-substituoidut fenyyli-4-oksibutaaniamiinijohdannaiset, menetel mä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostum ukset | |
| GR3019047T3 (en) | Heterocyclic-NMDA antagonists. | |
| FI942675A7 (fi) | Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi | |
| ZA914376B (en) | Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them | |
| AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
| DK0790994T3 (da) | Heterocyclisk substituerede propensyrederivater som NMDA-antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |